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Abstract 
Introduction:  The world prevalence of type 2 diabetes and its related 
increment mortality rate which needs high controls cost has attracted high 
scientific attention. Early detection of individuals who face this disease 
more than the others can prevent getting sick or at least reduce the disease 
consequences on public health. Regarding the costs and limitations of 
diagnostic tests, a statistical model is presented that helps predict the time 
of diabetes incidence and determines its risk factors. Furthermore, this 
model determines the significant predictor variables on response and 
considers them as model equation parameters. 
Materials and Methods: In this study, 803 pre-diabetic women in the 
age range of more than 20 years were selected from Tehran lipid and 
glucose study (TLGS) to examine the predictor variables on time of 
diabetes incidence. They were entered into the study in the phases 1 and 2 
and were followed up to the phase 4. The predictor variables selection 
was performed using the Stepwise Model (SM) and the Bayesian Model 
Averaging (BMA). Then, the predictive discrimination was used to 
compare the results of both models. The Log-rank test was performed and 
the Kaplan-Meier Curve was plotted. The statistical analyses were 
performed using R software (version 3.1.3). 
Results: The Backward Stepwise Model (BSM), the Forward Stepwise 
Model (FSM) and the BMA have used 9, 10 and 6 variables, respectively. 
Although the BMA selected predictor variables number is much lower 
than the SM, the prediction ability remains nearly constant. 
Conclusions: The BMA has averaged on the supported models using 
dataset. This model has shown nearly constant accuracy despite the 
selection of lower predictor variables number in comparison to the SM.  
 
Keywords: Bayesian Model Averaging; Stepwise Model; Tehran Lipid 














Cite this article as:  
Mehrabi Y, Mahdavi M, Khalili 
D,Baghestani A R ,Bagherzadeh-
Khiabani F  
Superiority of Bayesian Model Averaging 
to Stepwise Model in Selection of Factors 
Related to the Incidence of Type II 
diabetes in Pre-diabetic Women. Journal  
of Paramedical  Sciences 2019: 10(1). 
 
  
Journal of Paramedical Sciences 2019:10(1)                                                                       doi.org/10.22037/jps.v9i1.18370                                                 
 
   Superiority of Bayesian Model, Mehrabi Y et al.          
Journal of Paramdedical Sciences is an open access article under the terms of the Creative Commons Attribution -NonCommercial 4.0 International License,  
4 
1. Introduction 
     Diabetes is the most important metabolic 
human disease and an important factor in 
ischemic coronary artery disease [1]. Type 
2 diabetes risk factors include diabetes 
family history, obesity, age, high blood 
pressure and etc. [2]. Due to the personal 
and social disease burdens, it is important 
to identify its risk factors [3]. Recent World 
Health Organization (WHO) estimates 
shows that the diabetic patients percentage 
will be increased to 552 million by 2030 
[4]. Some reasons for the upward incidence 
and prevalence trend of type 2 diabetes in 
recent decades could be changes in 
lifestyle, prevalent obesity and low physical 
activity [5]. Before the disease onset, the 
person suffers from a condition known as 
the pre-diabetes; it means that a person's 
blood sugar is higher than normal level but 
not high enough to be considered as 
diabetic [6]. Because of the diabetes high 
risk among the pre-diabetics, it is suggested 
for these patients to be diagnosed for the 
diabetes risk factors. 
Many variables may be considered as risk 
factors for the diabetes development. 
Statistical methods such as logistic and 
survival regression models are usually 
employed to find and evaluate the most 
relevant subset of effective variables. In 
these regression models, a Stepwise Model 
(SM) is typically used to select a proper 
subset of variables [7]. One of the SM 
disadvantages is that it leads to the selection 
of a deterministic model, without 
considering the model uncertainties [8]. 
Lack of attention to the model uncertainty 
can lead to bias and inefficiency of the 
parameters estimation [9]. The Bayesian 
Model Averaging (BMA) can be used to 
take into account the model uncertainty. It 
averages on the possible models which 
weighted on models posterior probabilities 
[10, 11]. The basic principle of this model 
is that it treats models and their parameters 
as unobservable phenomena and estimates 
their distribution based on observable data 
[12]. Although uncertainty in the statistical 
models is well known, so far, few studies 
have been considering the uncertainty of 
the survival analysis models.  
The present study was carried out to 
identify the diabetes risk factors among the 
pre-diabetics by means of BMA. The BMA 
was used to select predictor variables that 
affect diabetes in pre-diabetics. Then, its 
performance is compared with the SM 
using Tehran Lipid and Glucose Study 
(TLGS). Regarding the diagnostic tests’ 
costs and limitations, a statistical model 
which helps to predict duration of the 
incidence was presented. Furthermore, this 
model determines the significant predictor 
variables on response and considers them as 
model equation parameters. 
 
2. Materials and Methods 
     In this cohort study, a dataset associated 
with 803 pre-diabetic women aged 20 years 
and over from TLGS participants were 
selected to investigate the predictor 
variables on the time of diabetes incidence. 
Therefore, there are no ethical 
considerations in this study. TLGS is a 
cohort study whose design details have 
been published elsewhere [13]. Women 
who had fasting blood sugar between 100 
and 125 or 2-h blood glucose between 140 
and 199 mg/dL were considered as pre-
diabetics. These women were entered into 
the first and second phases of TLGS and 
they were followed-up to the fourth phase. 
The follow-up lasted for 10-12 years. If at 
any phase, a person had a fasting blood 
sugar of 126 mg/dL or higher and/or 2-h 
blood glucose of 200 mg/dL or higher or 
taking blood glucose lowering medicine, 
she was diagnosed as a diabetic. The 
number of women who were recruited for 
the study from 803 persons were 734 who 
completed the study and their data were 
considered in data analysis [14]. The 
participants who left the study before the 
fourth phase died due to non-diabetes 
reasons or did not become diabetic by the 
fourth phase, were considered as a censor. 
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Initially, based on previous studies, 30 
predictor variables were selected as 
important clinical onset diabetes variables. 
These variables were examined for the co-
linearity presence. The chi-square and the t-
tests depending on the type of the variable 
were used in order to compare risk factors 
at baseline between participants who 
become diabetic and those who remained 
normal by the end of the study. The SM and 
the BMA were used to determine the 
factors associated with the time of diabetes 
incidence in pre-diabetic women using Cox 
proportional hazard regression. The 
Schoenfeld residuals were tested to assess 
the proportional hazards assumption of the 
Cox model. In addition, Schoenfeld 
residuals plots for all variables were 
plotted against log(time) in order to assess 
the presence of non-random process [15].  
The BMA uses the following equation 





where θ is a vector of parameters of interest 
and D represents the matrix of investigated 
data. The K proposed models are selected 
from the following set. 
, 
where set is selected by 
Occam’s Window approach. The posterior 
distributions of  DMP k ,  are averaged 
weighted on Pr( )kM D  in order to 
find . Equation (2) states that the 
models with posterior probability of less 
than 1/c of the maximum posterior 
probability are excluded from the BMA 
process. The c is a constant value which is 
selected by the data analyst depending on 
the  field of study.  In this study, c was 
fixed at 20 as proposed by Madigan and 
Raftery [16]. In the BMA, the variables 
selection were performed based on the 
posterior probability from variables with 
non-zero parameter estimates. For each 
parameter,  was obtained by 
summing up the posterior probabilities of 
models which include predictor variable 
( i). Predictor variables with 
  5.00  DP i were kept in the model 
[17].  
The SM and BMA were compared by 
predictive power after variable selection. 
Data of 734 participants in this study were 
randomly divided into two parts: 70 % for 
training and 30 % for model testing. The 
177 women out of 513 participants in 
training dataset and 80 ones out of 221 in 
test dataset became diabetic. The Cox 
proportional hazard models were fitted by 
each of the BMA and the SM based on the 
training dataset and then were evaluated for 
the test dataset.  
The predictive discrimination method was 
used to evaluate the models performance. 
For this purpose, firstly, all models of 
 set were fitted 
by the BMA in order to estimate the 
coefficients . The hazard scores 
were calculated for each person 
based on each fitted model using train 




Based on the calculated risk scores from 
training dataset, cut point of low and high 









 percentiles. The cut point was used 
for grouping participants in the test dataset. 
The predictive discrimination was obtained 
for the SM through the same way except 
that the calculations were conducted only 
for one model. The purpose of the 
predictive discrimination is that how 
correctly the model arranges the individuals 
into discrete low and high risk groups [18]. 
In addition, the Kaplan-Meier curve and the 
log-rank test were obtained for the BMA 
and the SM. The statistical analyses were 
performed using R software (version 3.1.3) 
[19]. 
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3. Results 
     In this study, 257 (25 %) of 734 pre-
diabetic women became diabetic by end of 
the study. The median time of diabetes 
incidence was 3204 days (8.78 years). 
Basic characteristics of the participants are 
shown in Table 1. The Schoenfeld residuals 
curve and test showed that the proportional 
hazard assumption is established for the 
Cox regression model (P-value = 0.067). 
In this study, 30 predictor variables were 
examined to include in the Cox model. To 
do this in an ordinary manner and 
considering that each variable can be 
selected or not, a set of 236 possible models 
had to be tested. The BMA using Leaps and 
bound algorithm [20] and Occam's window 
[21] method reduced the number of models 
into 68 models. Weighted averaging was 
done on these models based on the models 
posterior probabilities. Among them, five 
models with highest posterior probability 



























These top five models calculated 30.11 % 
of the total posterior probability, with the 
highest probability of 12.7 %. These results 
definitely indicated the models uncertainty.  
The BMA selected predictor variables that 
affect the incidence of diabetes among pre-
diabetic women are: age, fasting blood 
sugar, 2-h blood glucose, diabetes family 
history, hospitalization history during past 3 
months and body mass index (Table 3).  
BSM selected three additional variables of 
taking aspirin, enzyme drugs and diuretics. 
Furthermore, FSM selected waist-to-height 
ratio in addition to both models. 
Risk scores were calculated from training 
dataset, and cut point of low and high risk 









percentiles. In all cases, the BMA improved 
predictive performance but merely the 
results of 65
th
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Table 1. Baseline characteristics of pre-diabetic women aged>=20 for newly diagnosed diabetics and non-diabetics 
 Diabetic (n=257) Non-Diabetic  
(n=477) 
Quantitative variables   
2-h BG 151.1(25.8)  *  137(26.5)† 
FBS 103.8(10.3) 97.6(9.1)† 
TC 229.4(44) 220.1(42.4)‡ 
The ratio of TG to HDL 4.8(2.5) 4.2(2.4)‡ 
The ratio of TC to HDL 5.5(1.4) 5.1(1.4)‡ 
Cr .98(.11) .97(.11) 
Pulse pressure 45.3(14) 41.8(13.4)‡ 
DBP 82.6(9.9) 79.8(9.9) † 
WHtR .62(.06) .58(0.07) † 
BMI 30.8(4.4) 28.6(4.1) † 
HDL 42.8(9.5) 44.5(10.6)‡ 
Age 48.1(10.5) 44.7(11.7) † 
Survival time 1725(1029.8) 3315.9(676.4)† 
Qualitative variables   
Family history of diabetes 113(44)** 135(28.3) † 
History of hyperlipidemia 99(38.5) 119(24.9)† 
History of hospitalization 229(89.1) 420(88.1) 
History of hospitalization in the last 3 months 4(1.6) 10(2.1) 
History of pregnancy hypertension 21(8.2) 40(8.4) 
Baby more than 4.5 39(15.2) 42(8.8)‡ 
History of cardiovascular disease 27(10.5) 52(10.9) 
Having goiter 52(20.2) 97(20.3) 
The use of diuretics drugs 18(7) 12(2.5)‡ 
The use of thyroid drugs 21(8.2) 22(4.6) 
Use of enzymatic channel blockers drugs 6(2.3) 10(2.1) 
Aspirin 37(14.4) 36(7.5) ‡ 
Smoking in the past 4(1.6) 9(1.9) 
Smoking 7(2.7) 11(2.3) 
Less than a high school education 147(57.2) 204(42.8)† 
Marital status 34(13.2) 57(11.9) 
Having a thyroid nodule 22(8.6) 33(6.9) 
Intervention to Control Hypertension 31(12.1) 44(9.2) 
* Data for quantitative variables as mean (standard deviation) and **qualitative variables as number (percentage) 
‡ P less than 0.05 † P less than 0.001 compared with diabetic group 
DBP, diastolic blood pressure; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; FBS, fasting 
blood sugar; 2-h BG, 2-h blood glucose; Cr, Creatinine; BMI, Body mass index; WHtR, Waist-to-Height 
 
 












Age T T T --- --- 
FBS T T T T T 
Family history of diabetes T T T T T 
Aspirin --- --- T --- --- 
Hospitalization history during past 3 months T --- T --- T 
2-h BG T T T T T 
Use of enzymatic channel blockers drugs --- T --- --- --- 
BMI T T T --- --- 
Waist-to-Height --- --- --- T T 
No. of variables 6 6 7 4 5 
Posterior model probability 0.127 0.056 0.043 0.039 0.035 
BIC -169.17 -167.53 -167 -166.83 -166.60 
T is true (variable selected) 
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It presented that the BMA indicated higher 
predictive discrimination in comparison to 
BSM and FSM. The log-rank test showed a 
significant difference between low and high 






















This means that pre-diabetic women have 
been allocated to distinct risk groups. In 
addition, Kaplan-Meier curve indicated the 
distinction between low and high risk 








Table 3. Results of BMA and SM for the onset of type II diabetes in pre-diabetic women: TLGS 
Variable Bayesian Model Averaging  BSM FSM 
 Posterior mean Posterior sd P(   Coef (se) Coef (se) 
2-h BG .019 .002 1  0.019(0.002) 0.019(0.002) 
FBS .056 .006 1  0.056(0.006) 0.056(0.006) 
Family history of diabetes 0.492 .130 1  0.514(0.128) 0.512(0.128) 
BMI 0.045 .028 .766  0.061(0.014) 0.058(0.025) 
Hospitalization history during past 3 months -.813 .724 .67  -1.144(0.585) 
-
1.136(0.587) 
Age .011 .009 0.634  0.017(0.006) 0.016(0.006) 
WHtR 0.863 1.626 .243   0.263(1.673) 
Use of enzymatic channel blockers drugs -.163 .403 0.181  -0.891(0.493) 
-
0.886(0.494) 
Education 0.050 .127 0.169    
Aspirin .050 .146 0.131  0.415(0.187) 0.413(0.188) 
Pulse pressure 0.0004 .002 0.059    
Marital status 0.016 .081 0.058    
Use of thyroid drugs .018 .099 0.047    
The use of diuretic drugs 0.010 .077 0.031  0.392(0.264) 0.392(0.264) 
Baby more than 4.5 .001 .023 .011    
Goiter status .001 .021 .011    
DBP 0.00005 .0008 0.011    
HDL -.00006 .0009 0.011    
Cr -.003 .068 .01    
TC -.00001 .0001 .01    
Former smokers -.002 .057 .01    
History of hospitalization -.0009 .021 .009    
History of thyroid nodules 0.001 0.024 0.009    
Cigarette .001 .038 .009    
History of cardiovascular disease .0001 .017 0.008    
Prevention for control hypertension -.0003 .019 .008    
History of hyperlipidemia .0001 .012 .008    
History of pregnancy hypertension -.0006 .022 .008    
The ratio of TC to HDL 0.00001 .003 .008    





Table 4. Classification of diabetes in low-risk and high-risk groups by predictive discrimination 
Method Risk group Non-diabetic Diabetic 
BMA    
 
Low risk 106(75.18) 31(38.75) 
High risk 35(24.82) 49(61.25) 
BSM    
 
Low risk 103(73.05) 37(46.25) 
High risk 38(26.95) 43(53.75) 
FSM    
 
Low risk 104(73.76) 38(47.5) 
High risk 37(26.24) 42(52.5) 
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Figure1. Kaplan-Meier plot for the onset of type II diabetes in Bayesian model averaging 
 
 



























Figure 2. Kaplan-Meier plot for the onset of type II diabetes in the FSM 
 
 



























Figure 3. Kaplan-Meier plot for the onset of type II diabetes in the BSM 
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10 and 6 predictor variables on time of 
diabetes incidence, respectively. 
In this study, the SM variable selection 
based on the AIC and the BMA were 
investigated in the Cox regression model. 
SM procedures involved three basic steps: 
identifying an initial model; iteratively 
‘stepping’: repeatedly altering the model at 
the previous step by adding or removing a 
predictor variable in accordance with the 
‘stepping criteria’ and terminating the 
search when stepping is no longer possible, 
given the stepping criteria (AIC). The BMA 
showed better prediction performance 
compared to the SM despite the smaller 
number of variables selection. 
 
4. Discussion 
     In this study, five models with the 
highest posterior probabilities were selected 
by the BMA. They showed that several 
models with non-negligible posterior 
probabilities exist but yield different 
results. It indicates the significance of the 
model uncertainty. Therefore, the BMA 
could be useful in this case [22]. In fact, its 
solution for the model uncertainty is 
investigating the quantity of interest using 
the subset of supported models by data and 
then performing statistical inference using 
the weighted average of models posterior 
distributions [23-25]. This model presents 
the numerical size of the competing models 
desirability [18] and overcomes the 
weakness of the individual models. Thus, it 
must be reliable and accurate [7, 26] . In 
this paper, the uncertainty between models 
was considered using the BMA and a small 
number of variables were selected at the 
same time, leading to higher accuracy 
prediction. 
The BMA uses Leaps and bound algorithm 
to reduce the number of models. This 
algorithm does not check all the possible 
models. Thus, there is still some uncertainty 
that has not been calculated; this sort of 
uncertainty is unavoidable. Nevertheless, 
because it tries to find all the important 
models, this additional uncertainty is 
negligible [10]. The difference between the 
BMA and the SM is that the BMA results 
for possible effects are adjusted for all the 
predictor variables [7]. This model presents 
a measure of model uncertainty through the 
posterior probability [27] and it also 
prevents the dual mode selection for 
variable effectiveness using continuous 
scale (0-1) and considers the model 
uncertainty; hence, it increases the models 
validity [23]. Doming compared the BMA 
with the model combination methods and 
showed that BMA has worse performance 
[28]. This conclusion is unfitting because 
the BMA is not an algorithm for the model 
combination. The model combination 
works through powering assumption space, 
and not through estimation of the BMA 
[29]. 
In this study, the Kaplan-Meier curves 
showed higher accuracy prediction of the 
BMA. A disadvantage of the SM is the 
instability of variable selection. Altman and 
Andersen used one hundred Bootstrap 
samples of a dataset in order to investigate 
the stability of Cox model selection 
process. They found that the SM Cox 
model resulted in different sets of 
independent variables.  They concluded the 
instability of variable selection using the 
SM for Cox model [30]. In the SM, the 
deduction is based on type I and II errors. 
The SM may lead to the overestimation in 
coefficients and underestimation of the 
standard deviation and therefore incorrect 
P-values [8]. Thus, this method does not 
consider the models uncertainty [9]. On the 
other hand, it should be noted that 
censorship in survival regression models 
may increase the uncertainty. 
Variable selection in the BMA is based on 
the probability of a variable posterior effect. 
Thus, it solves the binary problem (variable 
selection or non-selection). The results of 
this study showed that in the BMA, the 
predictor variables of age, fasting blood 
sugar, 2-h blood glucose, family history of 
diabetes, BMI, and hospitalization history 
during past 3 months can effect on time of 
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diabetes incidence in pre-diabetic women. 
These variables were selected by SM. 
In BMA, BMI was selected as risk factor, 
while waist-to-height was not. However, 
the probability of posterior effect for waist-
to-height is 0.243. This value showed that 
the waist-to-height variable in the presence 
of stronger variable of BMI was not 
selected. The FSM manifested that in 
addition to the BMI, the waist-to-height 
variable was effective on the time of 
diabetes incidence but the BSM was 
selected only for the BMI. The adjusted 
BMA is in the presence of all the variables 
and it presents the effective intensity of all 
the variables in the continuous scale. Thus, 
clinically, it is a flexible model. The Leaps 
and bounds algorithm in the BMA is not 
desirable for more than 30 variables, and 
this is one of the limitations of this method. 
 
5. Conclusion 
     In the present study, the BMA shows 
nearly a constant accuracy despite the 
selection of lower predictor variables 
number in comparison to the SM. 
Consequently, it seems that the BMA has 
presented better performance for the 
evaluation of the predictor variables on the 
time of diabetes incidence. 
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